We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+14.6%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$500B
AUM Growth
+$33.8B
Cap. Flow
-$25.4B
Cap. Flow %
-5.08%
Top 10 Hldgs %
30.95%
Holding
15,795
New
1,585
Increased
6,018
Reduced
6,315
Closed
1,625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.38B
2
NVDA icon
NVIDIA
NVDA
+$732M
3
AMZN icon
Amazon
AMZN
+$606M
4
DIS icon
Walt Disney
DIS
+$559M
5
T icon
AT&T
T
+$466M

Sector Composition

Rank Sector Weight
1 Technology 3.81%
2 Healthcare 2.95%
3 Financials 2.19%
4 Consumer Discretionary 2.15%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XGN icon
13951
PUT
Exagen
XGN
$161M
$398 ﹤0.01%
+200
New +$346
FIACW
13952
DELISTED
Focus Impact Acquisition Corp. Warrant
FIACW
$395 ﹤0.01%
18,971
-7,511
-28% -$295
NSLR
13953
CALL
Neostellar Capital Corp
NSLR
$278M
$394 ﹤0.01%
100
NEXRW
13954
Nexera Technologies Ltd Warrant
NEXRW
$57.6K
$393 ﹤0.01%
22,202
+300
+1% +$8
HOWL icon
13955
PUT
Werewolf Therapeutics
HOWL
$19.7M
$386 ﹤0.01%
+100
New +$255
ADVM
13956
CALL
DELISTED
Adverum Biotechnologies
ADVM
$376 ﹤0.01%
50
-1,520
-97% -$13.9K
TARA icon
13957
PUT
Protara Therapeutics
TARA
$235M
$374 ﹤0.01%
200
-800
-80% -$1.18K
TBRG
13958
DELISTED
TruBridge
TBRG
$358 ﹤0.01%
32
-192,605
-100% -$2.44M
IMAQR
13959
DELISTED
International Media Acquisition Corp. Rights
IMAQR
$357 ﹤0.01%
+10,206
New +$446
BTCY
13960
CALL
DELISTED
Biotricity, Inc. Common Stock
BTCY
$354 ﹤0.01%
+300
New +$400
LNSR icon
13961
CALL
LENSAR
LNSR
$101M
$351 ﹤0.01%
100
-6,900
-99% -$17.1K
OESX icon
13962
CALL
Orion Energy Systems
OESX
$79.1M
$347 ﹤0.01%
40
-20
-33% -$197
FTCI icon
13963
CALL
FTC Solar
FTCI
$38.7M
$346 ﹤0.01%
50
-2,270
-98% -$20.6K
USIO icon
13964
CALL
Usio Inc
USIO
$76.2M
$344 ﹤0.01%
200
-4,800
-96% -$8.79K
GTACW
13965
DELISTED
Global Technology Acquisition Corp. I Warrant
GTACW
$337 ﹤0.01%
11,258
BOCNW
13966
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
$323 ﹤0.01%
16,125
+2,679
+20% +$54
REAX icon
13967
PUT
Real Brokerage
REAX
$523M
$320 ﹤0.01%
200
+100
+100% +$146
GRTX
13968
CALL
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$320 ﹤0.01%
2,200
-300
-12% -$47
PRENW
13969
Prenetics Global Ltd Warrant
PRENW
$128K
$316 ﹤0.01%
21,185
+592
+3% +$9
INTA icon
13970
Intapp
INTA
$3.09B
$304 ﹤0.01%
8
BRBS icon
13971
PUT
Blue Ridge Bankshares
BRBS
$331M
$303 ﹤0.01%
+100
New +$306
AIRJW
13972
AirJoule Technologies Warrant
AIRJW
$89M
$299 ﹤0.01%
10,010
-6,126
-38% -$462
ASCBW
13973
DELISTED
A SPAC II Acquisition Corp. Warrant
ASCBW
$295 ﹤0.01%
50,899
+495
+1% +$7
STIM icon
13974
PUT
Neuronetics
STIM
$230M
$290 ﹤0.01%
100
-4,000
-98% -$6.31K
MLSS icon
13975
PUT
Milestone Scientific
MLSS
$43.8M
$276 ﹤0.01%
400
-100
-20% -$80

Similar funds

Ken Griffin's Q4 2023 Portfolio in Review

As of Q4 2023, Ken Griffin held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $25.4B in Q4 2023, closing 1,625 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.

  • Ken Griffin's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
  • Ken Griffin's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
  • Ken Griffin fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
  • Ken Griffin's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
  • Ken Griffin opened 1,585 new positions and closed 1,625 in Q4 2023.
  • Ken Griffin's portfolio value rose 7.2% quarter-over-quarter to $500B.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.